Back

Retrospective review of primary prevention implantable cardiac defibrillator insertions for heart failure with reduced ejection fraction

19 May 2025 (09:00 - 10:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment (1) Treatment HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Aafreen Khalid

Royal Adelaide Hospital, Adelaide (Australia)

7 More presentations in this session

Presentation thumbnail
Effect of improving utilization of guideline-directed medical therapy for heart failure.
Mr J. Ferraro (Penafiel, PT)
Abstract Slides Video
Presentation thumbnail
Transcatheter edge-to-edge mitral valve repair: a meta-analysis of hospitalization outcomes in heart failure and secondary mitral regurgitation
Doctor E. Mata (Creixomil, PT)
Abstract Slides Video
Presentation thumbnail
A meta-analysis of quality of life outcomes after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation
Doctor B. Lage Garcia (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Effective regurgitant orifice area and left ventricular volume impact on hospitalizations effects of transcatheter edge-to-edge mitral valve repair: a meta-regression analysis
Doctor B. Lage Garcia (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Stroke volume assessment by pocus in patients with heart failure undergoing electrical cardioversion to reverse atrial fibrillation to sinus rhythm
Mrs A. Freitas (Curitiba, BR)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment (1)

The Event

Event poster

Heart Failure 2025

19 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator therapies in primary prevention are not decreased in a contemporary cohort: insights from long-term follow-up
thumbnail
Congress Presentation
Real-life management of heart failure: evaluation of medication optimisation in different phenotypes.
thumbnail
Congress Presentation
Non-ischemic cardiomyopathy patient's survival results of the intracardiac device implanted versus medical therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources